NCT07141225

Brief Summary

The detection rate of renal masses smaller than 7 cm has significantly increased in recent years. To preserve postoperative renal function to the greatest extent possible, guidelines from the European Association of Urology (EAU), the National Comprehensive Cancer Network (NCCN), and others have endorsed partial nephrectomy (PN) as the preferred treatment strategy for small renal masses. In conventional PN, it is necessary to clamp the renal artery or its branch arteries and employ a double-layer suturing technique to close the resection bed. This controls bleeding, maintains a clear surgical field, and prevents postoperative urinary leakage. The maximum safe duration of warm ischemia to avoid irreversible renal parenchymal damage remains controversial, though most studies indicate a window of 20-30 minutes. Consequently, the "off-clamp sutureless" concept has gained prominence. Its core principle is to avoid renal artery clamping and replace suturing with novel haemostatic techniques, thereby maximizing the preservation of healthy renal parenchyma. With the diversification of haemostatic material options and the widespread adoption of robotic-assisted systems, the off-clamp sutureless strategy has become technically feasible for small renal masses with low complexity . Multiple retrospective studies demonstrate that the off-clamp sutureless technique is non-inferior, offering safety and surgical outcomes comparable to conventional robot-assisted partial nephrectomy (RAPN). However, it is important to note that current research predominantly focuses on tumors ≤4 cm, is largely retrospective, and suffers from limited sample sizes. More robust, evidence-based medical evidence is required to support its application for larger tumors or those with complex anatomy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
190

participants targeted

Target at P75+ for not_applicable

Timeline
27mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Jun 2025Jun 2028

Study Start

First participant enrolled

June 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 26, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

September 5, 2025

Status Verified

August 1, 2025

Enrollment Period

2 years

First QC Date

August 19, 2025

Last Update Submit

August 28, 2025

Conditions

Keywords

robot-assisted partial nephrectomyoff-clampsuturelesspostoperative renal function preservation

Outcome Measures

Primary Outcomes (1)

  • Bilateral Kidney GFR

    Measured by 99mTc-DTPA

    3 months after surgery

Secondary Outcomes (2)

  • Perioperative Complication Rate

    1 week after surgery

  • Intraoperative Blood Loss

    during surgery

Study Arms (1)

Off-Clamp Sutureless Group

EXPERIMENTAL
Procedure: Off-Clamp Sutureless Technique

Interventions

During the procedure, the renal artery and its branches are not clamped. The tumor is completely resected with a gross margin of 0.5-1 cm from its edge. Monopolar or bipolar electrocautery is used for hemostasis during resection. Following tumor removal, the renal resection bed is subjected to meticulous hemostasis, followed by the application of hemostatic agents without suture closure.

Off-Clamp Sutureless Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 80 years old, regardless of gender;
  • Radiological findings demonstrating a tumor size of ≤7 cm;
  • Imaging studies showing no evidence of collecting system invasion;
  • Scheduled to undergo robot-assisted partial nephrectomy (RAPN).

You may not qualify if:

  • Preoperative imaging demonstrating evidence of distant metastasis or lymph node involvement;
  • Unilateral or bilateral multiple lesions not amenable to simultaneous resection;
  • History of prior systemic therapy, including molecular targeted therapy, immunotherapy, or chemotherapy;
  • Intraoperative conversion to radical nephrectomy;
  • Intraoperative conversion to open surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

Nanjing, Jiangsu, 210036, China

RECRUITING

MeSH Terms

Conditions

Urologic DiseasesKidney Neoplasms

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsKidney Diseases

Study Officials

  • Pengfei Shao, Professor

    The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital), Nanjing, Jiangsu 210036

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pengfei Shao, Professor

CONTACT

Haoqi Miao, Postgraduate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 19, 2025

First Posted

August 26, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 30, 2028

Last Updated

September 5, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Without obtaining prior consent from the participant.

Locations